Role of Sympathetic Nerve Activity in Obesity, Hypertension and Metabolic Syndrome

By  

Current Hypertension Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 83-91

Bentham Science Publishers

Access to resources Recommend Favorite

Prevalence of Obesity, Hypertension, Diabetes, and Metabolic Syndrome and Its Cardiovascular Complications

By  

Current Hypertension Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic:Current Hypertension Reviews, Hot Topics “Obesity, Hypertension, and the Metabolic Syndrome” (Guest Editor: Kazuko Masuo)]

By  

Current Hypertension Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 72-72

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin Resistance, Obesity and the Metabolic Syndrome. Is there a Therapeutic Role for Endothelin-1 Antagonists?

By  

Current Vascular Pharmacology, Vol. 3, Iss. 4, 2005-10 ,pp. : 359-363

Bentham Science Publishers

Access to resources Recommend Favorite

Relationships of Beta2- and Beta3--Adrenoceptor Polymorphisms with Obesity, Hypertension and Metabolic Syndrome

By  

Current Hypertension Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 118-129

Bentham Science Publishers

Access to resources Recommend Favorite